Pricing Log in Create free account

Actuate Therapeutics, Inc. (ACTU) vs BioStem Technologies, Inc. (BSEM)

Actuate Therapeutics, Inc. and BioStem Technologies, Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and BioStem Technologies, Inc. are of similar size ($19.4M and $18.0M). Actuate Therapeutics, Inc. has the higher net margin (0.00% vs −76.0%) and the lower return on invested capital (0.00% vs 55.3%). Across the 11 metrics below, BioStem Technologies, Inc. leads on 7 and Actuate Therapeutics, Inc. on 4.

Valuation

Metric ACTU BSEM Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.56 9.40
P/B 7.72 0.70 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.68 0.66
EV/Sales n/m 0.36 9.02
Earnings yield (271.88%) (137.92%) (32.88%)
Free cash flow yield (259.67%) 0.00% (23.13%)

Profitability

Metric ACTU BSEM Biotechnology median
Gross margin — 91.16% 68.51%
Operating margin 0.00% 52.87% 0.00%
Net margin 0.00% (76.02%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 2,457.65% 0.00% (51.96%)
Return on assets (336.18%) 0.00% (46.06%)
Return on invested capital 0.00% 55.34% 0.00%

Growth

Metric ACTU BSEM Biotechnology median
Revenue growth (TTM) — (87.14%) 6.76%
EPS growth (last fiscal year) 67.48% (126.53%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric ACTU BSEM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 0.98 4.97
Net debt to EBITDA 0.59 0.00 1.01

Dividend

Metric ACTU BSEM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACTU BSEM Biotechnology median
Market cap 17.98m 19.42m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack